Ixazomib, Lenalidomide, and Combination for Maintenance in NDMM Patients

Clinical trial NCT04217967 · COMPLETED

Trial details

NCT number: NCT04217967
Sponsor: Peking Union Medical College Hospital
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2019-09-24
Primary completion: 2024-06-30
Enrollment: 211

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.